GLP-2 Tirzepatide GLP-2 (Tirzepatide) Injectable GLP-2 Tirz (40mg) Injectable Category: Weight Loss & Metabolic Health Tirzepatide is a dual agonist peptide that targets both the GLP-1 (glucagon-like peptide-1) receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor
PlexusDx Precision Peptide Genetic Test maps 14 metabolic pathways and 49 peptide-related genes to reveal how your unique genetics influence GLP-1 sensitivity, insulin response, and weight regulation potential
People were tested on these weekly doses: 1 milligram (mg) 4 mg (starting at either 2 mg or 4 mg) 8 mg (starting at either 2 mg or 4 mg) 12 mg (starting at 2 mg) The highest dose tested was 12 mg per week , and the gradual increase was important for making side effects easier to handle
Describe how GLP-1 medications affect appetite regulation, insulin secretion, and gastric emptying, and consider how these physiological changes may influence individuals health behaviors and psychosocial well-being. 2
Avoiding high-fat and high-sugar foods Avoiding these types of foods are particularly important for managing nausea
